General information on clinical studies
The clinical testing of medicines is a frequent form of clinical study (also known as AMG studies). If a promising active substance has been discovered or developed through basic research, it is first tested intensively in the laboratory (pre-clinical phase). If results from the pre-clinical phase are also positive and official approval is given, clinical testing begins.
Other clinical studies can include the testing of other new possibilities (e.g. surgical) for medical treatment and diagnosis. Epidemiologically and pathophysiologically oriented studies (e.g. genetic) are carried out with the aim of constantly extending our understanding of diseases.
The advantage for the study patient is access to new means of prevention, treatment or diagnosis. Moreover, specialist investigating doctors provide close attentive medical care within a framework of comprehensive explanation and intensive support from the entire study team. Finally, by participating, the patient is contributing to medical progress, from which future patients will also benefit.
In the course of the study, you will be invited to a number of “visits” at which the doctor will examine you. During these appointments, the doctor has a chance to observe how the new therapy is working and whether it is well tolerated, and/or whether the new diagnostic measure can provide the expected results
What studies are currently running at the NCRC Central Campus?
Here you can find more information on current studies at the NCRC.